Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Devices@FDA
  • Print
  • Share
  • E-mail
-
 
Help | Download Files | More about PMA

New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceENLITE SENSOR
Generic NameAutomated insulin dosing , threshold suspend
ApplicantMedtronic, Inc.
18000 Devonshire St.
Northridge, CA 91325
PMA NumberP120010
Supplement NumberS029
Date Received07/11/2014
Decision Date11/12/2015
Product Codes MDS OZO 
Advisory Committee Clinical Chemistry
Clinical TrialsNCT01112696
Supplement TypeNormal 180 Day Track
Supplement Reason Change Design/Components/Specifications/Material
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
RecallsCDRH Recalls
Approval Order Statement  
APPROVAL FOR AN INCOMING RECEIVING MATERIAL SPECIFICATION CHANGE OF A CRITICAL DEVICE COMPONENT (GOX) USED IN THE SENSOR FABRICATION PROCESS FOR THE ENLITE SENSOR (MMT-7008) AND SOF-SENSOR (MMT-7002, MMT-7003). THESE SENSORS ARE COMPONENTS OF THE MINIMED 530G SYSTEM AND PARADIGM REAL-TIME SYSTEM, PARADIGM REAL-TIME REVEL SYSTEM, GUARDIAN REAL-TIME CGM SYSTEM, MINILINK REAL-TIME SYSTEM, IPRO RECORDER CGM SYSTEM, AND IPRO2 PROFESSIONAL CGM SYSTEM, RESPECTIVELY.
Post-Approval StudyShow Report Schedule and Study Progress
  We welcome your comments and feedback about Devices@FDA.
-
-